TO-1187

TO-1187 : Degrader (PROTAC) of HDAC6

Structure

Information

  • HDAC6
  • Degrader (PROTAC)
  • 100 nM up to 1 µM; Hook effect at 10 µM

In Vitro Validations

Uniprot ID: Q9UBN7
Target Class: Epigenetic
Target SubClass: Histone deacetylase
Potency: IC50
Potency Value: 4.6 nM
Potency Assay: Electrophilic Mobility Shift Assay (EMSA)
PDB ID for probe-target interaction (3D structure): --
Target aliases:
Protein deacetylase HDAC6, KIAA0901, HDAC6, HDAC6_ ...

DOI Reference: 10.1021/acs.jmedchem.4c02021

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency assay, off target (cells): Cellular concentrations of three HDAC isoforms (HDACs 3, 6, and 8) in human multiple myeloma cell line, MM.1S were evaluated after 1 uM treatment for 6 h.
Probe Selectivity in Cell:
Nearly complete degradation of HDAC6 was observed at a single concentration of 1 μM, and no significant change was observed in the levels of both HDAC3 and HDAC8.
Potency assay, off target (cells): Global Degradation Proteomic Analysis of TO-1187: MM.1S cells were exposed to two different concentrations (10 nM and 100 nM) of TO-1187, and cell pellets were collected after a 6 h incubation period.
Probe Selectivity in Cell:
At a concentration of 100 nM, TO-1187 exhibited a distinct degradation pattern. Specifically, TO-1187 caused a substantial reduction in the levels of HDAC6 protein without affecting the levels of other proteins including other HDACs. //no decrease was also observed in the protein levels of prominent IMiD-based neosubstrates, including IKZF1, IKZF3, CK1α, and GSPT1, demonstrating the specificity of TO-1187 for HDAC6 degradation. At a lower concentration of 10 nM, TO-1187 had no appreciable impact on the overall abundance of any of the cellular proteins detected and quantified.
Potency assay, off target (cells): Immunoblotting for IKZF1, IKZF3, and GSPT1 in MM.1S cells 6 h after treatment with 100 nM TO-1187 showed that TO-1187 did not induce any detectable depletion of these neo-substrates.
Potency assay (off target): In vitro inhibitory activity against four HDACs (HDACs 3, 6, 8, and 11) was assessed using an electrophilic mobility shift assay (EMSA). showing selectivity for HDAC6
I have extra information to add

SERP ratings and comments


No SERP comments found for TO-1187